Loading...
OTCM
NHZHY
Market cap815mUSD
, Last price  
USD
Name

New Horizon Health Ltd

Chart & Performance

D1W1MN
OTCM:NHZHY chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
765m
+259.54%
18,816,00058,275,00070,567,000212,761,000764,960,000
Net income
-79m
L-97.45%
-224,869,000-106,465,000-788,724,000-3,106,040,000-79,238,000
CFO
-413m
L+16.34%
-55,826,000-74,988,000-132,302,000-354,594,000-412,538,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

New Horizon Health Limited functions as an investment holding company, primarily focusing on the research and development of screening products for various cancers, including colorectal and cervical, within the People's Republic of China. The firm also engages in the advancement of medical diagnostic technology. Its operations extend to providing a range of services such as technical support, technology transfers, consulting, medical assistance, and financing. Furthermore, the company manufactures and distributes medical and laboratory equipment, notably specialized fecal occult blood test kits, and is involved in technology import and export activities. Established in 2013, its headquarters are located in Hangzhou, China.
IPO date
Feb 18, 2021
Employees
1,041
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT